UNSPSC 51452404: Diphenan

This classification denotes an antihelminthic agent with the molecular formula C14H13NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U129BBY8DB, chemically known as 4-(phenylmethyl)phenol, carbamate but generally known as diphenan, which bears US NIH Compound Identifier 7572. European Medicines Agency schedules Diphenan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07210MIG. The term DIPHENAN is an International Non-Proprietary Name.

UNSPSC 51452404 Diphenan (Commodity) covers pharmaceutical products, with recent state and local solicitations reflecting procurement of specific antibiotic and public-health pharmaceuticals rather than diphenan formulations alone. The code captures how state health departments, county health authorities, and other local public bodies source pharmaceutical inventory through competitive bidding and cooperative purchasing agreements. Work solicited under this Commodity includes warehouse supply contracts for specific tablet formulations with defined expiration dates and packaging requirements, as well as community health procurement of naloxone and related pharmaceutical systems. Issuing bodies are primarily state departments of health and county health or public health authorities executing formal bid processes to secure pharmaceutical supply.

Activity under the code spans multiple states, with recent opportunities posted from Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets across a 12-month initial term with renewal options, awarded under an Invitation for Bid process. Seminole County, Florida released an IFB on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2026, and vendor selection to be made on a fixed-fee competitive basis. Both solicitations required full shipping and delivery cost inclusion and E-Verify compliance.